KLK6 and Alzheimer disease: In human CSF, neurosin has been identified in its inactive proform [32] and examination of CSF, plasma and brain tissue extracts from AD patients versus controls have revealed altered neurosin expression and subsequently the protein was suggested as a potential AD biomarker [33], [34] as well as a risk factor for developing AD [35].